JP Morgan Chase
PRCT icon

JP Morgan Chase’s Procept Biorobotics PRCT Stock Holding History

JP Morgan Chase’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.38M Buy
279,908
+8,677
+3% +$217K ﹤0.01% 3221
2026
Q1 		$6.93M Buy
271,231
+224,087
+475% +$6.31M ﹤0.01% 3013
2025
Q4 		$1.48M Sell
47,144
-560,785
-92% -$18.6M ﹤0.01% 4331
2025
Q3 		$21.7M Sell
607,929
-157,068
-21% -$7.17M ﹤0.01% 2032
2025
Q2 		$44.1M Buy
764,997
+48,664
+7% +$2.75M ﹤0.01% 1404
2025
Q1 		$41.7M Buy
716,333
+101,167
+16% +$6.91M ﹤0.01% 1417
2024
Q4 		$49.5M Sell
615,166
-197,200
-24% -$16.8M ﹤0.01% 1336
2024
Q3 		$65.1M Sell
812,366
-84,381
-9% -$5.99M ﹤0.01% 1171
2024
Q2 		$54.8M Buy
896,747
+823,558
+1,125% +$49M ﹤0.01% 1200
2024
Q1 		$3.62M Sell
73,189
-47,058
-39% -$2.24M ﹤0.01% 3371
2023
Q4 		$5.04M Sell
120,247
-2,608
-2% -$88.8K ﹤0.01% 3077
2023
Q3 		$4.03M Buy
122,855
+896
+0.7% +$30.5K ﹤0.01% 2994
2023
Q2 		$4.31M Buy
121,959
+40,843
+50% +$1.35M ﹤0.01% 2986
2023
Q1 		$2.3M Buy
81,116
+51,679
+176% +$1.82M ﹤0.01% 3446
2022
Q4 		$1.22M Buy
29,437
+3,212
+12% +$138K ﹤0.01% 3913
2022
Q3 		$1.09M Sell
26,225
-39,189
-60% -$1.56M ﹤0.01% 3930
2022
Q2 		$2.14M Buy
65,414
+60,061
+1,122% +$2.18M ﹤0.01% 3486
2022
Q1 		$188K Buy
5,353
+825
+18% +$19.9K ﹤0.01% 5227
2021
Q4 		$113K Buy
+4,528
New +$167K ﹤0.01% 5618

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase's PRCT Position: Q2 2026 in Review

JP Morgan Chase increased its Procept Biorobotics (PRCT) stake by 3.2% in Q2 2026, buying an estimated $217K and bringing the position to 279,908 shares worth $6.38M. The position accounts for ﹤0.01% of the portfolio, ranked #3221.

JP Morgan Chase first reported a position in PRCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $65.1M in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • JP Morgan Chase held 279,908 shares of Procept Biorobotics worth $6.38M as of Q2 2026.
  • JP Morgan Chase bought 8,677 Procept Biorobotics shares in Q2 2026, an estimated $217K.
  • Procept Biorobotics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3221 holding.
  • JP Morgan Chase first reported a position in Procept Biorobotics in Q4 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's Procept Biorobotics position peaked at $65.1M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.